www.abbvie.com

Contact Information:

Paula Johnson
[email protected]
608-438-7868

AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader.

Delayed Appropriate Therapy (DAT) in Serious Gram-Negative Infections: A Cause of Increased Morbidity, Length of Stay (LOS), and Hospital Costs

For information about Avycaz please click below:

• AST Susceptibility Information Sheet
• Stay Informed on the in vitro activity of AVYCAZ
• AVYCAZ Adult and Pediatric Dosing Card

For more information about Teflaro please click below:

• TEFLARO CABP Guidelines
• TEFLARO Adult CABP Information
• TEFLARO Adult ABSSSI Information
• TEFLARO CABP-ABSSSI Information

Virtual Drop In:

Friday, October 16, 2020 
12:15-1:10 pm

Access the virtual drop in